Article Text

Download PDFPDF
15 Non-ischaemic cardiomyopathy and cardiac resynchronization therapy– revisiting the ‘at risk’ patient profile
  1. V Voon,
  2. WY Lau,
  3. H Pereira,
  4. N Shanmugam,
  5. R Ray,
  6. L Anderson
  1. St George’s University Hospital NHS Foundation Trust, London, United Kingdom


Background Non-ischaemic cardiomyopathy has been associated with better left ventricular (LV) remodeling and outcomes post-cardiac resynchonization therapy (CRT) but has separately been linked to poorer outcomes when associated with mid-wall fibrosis (MWF) on cardiac magnetic resonance. Therefore, we aimed to confirm the impact of MWF in patients with non-ischaemic cardiomyopathy and CRT.

Methods We retrospectively evaluated data from 110 consecutive patients with a diagnosis of non-ischaemic cardiomyopathy and CRT implants. Non-eligible patients were excluded (eg. ischaemic, amyloid or sarcoid cardiomyopathy, missing data). Patients with or without mid wall fibrosis (MWF+, n=57 vs MWF-, n=53), were compared and evaluated for long-term outcomes of all-cause mortality or hospitalizations for ventricular arrthythmias or heart failure from time of CRT implant (figure 1). Results were reported as mean ±SD. p≤0.05 was deemed statistically significant.

Abstract 15 Figure 1

Kaplan-Meier demonstrating no significant difference in all cause mortality between patients with non-ischaemic cardiomyopathy and cardiac resynchronization therapy implants with or without mid wall fibrosis (MWF+ vs MWF-) over follow-up

Results Mean age of patient cohort was 67±14 years with total follow-up duration of 900±692 days. Between the groups, no significant difference in baseline demographics was observed in terms of age, gender, comorbidities (hypertension/diabetes), medication profiles, electrocardiographic measures (intrinsic rhythm and QRS duration), and LV ejection fraction. However, MWF+ demonstrated higher LV end-diastolic volume and LV end-systolic volume compared to MWF- (271±81 vs. 232±85 ml; 193±79 vs 160±79 ml, respectively, all p<0.05). Despite that, there were no significant between-group differences in all-cause mortality or hospitalizations for ventricular arrhythmia or heart failure over the follow-up duration.

Conclusion This retrospective study showed that MWF+ was associated with higher LV end-diastolic volumes and end-systolic volumes compared to MWF-. However, no significant impact was observed in MWF+ on long-term cardiac outcomes in patients with non-ischaemic cardiomyopathy and CRT. Further evaluation in larger studies is warranted.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles